Table 3.

Baseline Characteristics of 61 Patients Undergoing Down-Staging

Median age, years (range)	59 (45–73)
Sex (M/F)	50/11
Asian, n (%)	19 (31%)
Child class cirrhosis (A/B/C)*	29/25/7
Cause of liver disease, n (%)
Hepatitis C virus	36 (59)
Hepatitis B virus	15 (25)
Other	10 (16)
Median AFP, ng/mL (range)†	28 (3–6,539)
HCC characteristics before down-staging, n (median [range] of maximal tumor diameter)
One lesion	25 (6.4 cm [5.2–8 cm])
Two lesions	20 (4.2 cm [3.2–5 cm])
Three lesions	11 (4.6 cm [3.7–5 cm])
Four or five lesions	5 (2.6 cm [2.2–3 cm])
Histologic confirmation of HCC at or before down-staging, n (%)	38 (62)

^*Child class A, B, and C correspond to CTP scores of 5– 6, 7–9, and 10–15, respectively.

^†Baseline AFP before down-staging treatment was missed in one patient.